« MediaWiki:ContentImporter-wikidoc-postponed.json » : différence entre les versions
(Ajout item reporté) |
(Ajout item reporté) |
||
(80 versions intermédiaires par un autre utilisateur non affichées) | |||
Ligne 1 : | Ligne 1 : | ||
[ | [ | ||
"11β-hydroxylase deficiency (patient information)", | "11β-hydroxylase deficiency (patient information)", | ||
"Abdominal enlargement", | "Abdominal enlargement", | ||
"Abdominal pain", | "Abdominal pain", | ||
"Accommodative insufficiency", | "Accommodative insufficiency", | ||
"Acid indigestion", | "Acid indigestion", | ||
Ligne 18 : | Ligne 9 : | ||
"Anosmia", | "Anosmia", | ||
"Anxiety", | "Anxiety", | ||
"16PF Questionnaire", | "16PF Questionnaire", | ||
"16 Personality Factors", | "16 Personality Factors", | ||
Ligne 98 : | Ligne 88 : | ||
"ACGT", | "ACGT", | ||
"ACUITY HORIZONS bleeding criteria", | "ACUITY HORIZONS bleeding criteria", | ||
"ACVBP-R regimen" | "ACVBP-R regimen", | ||
"Abdominal bruit", | |||
"AC regimen", | |||
"AD-36", | |||
"ADHD predominantly inattentive", | |||
"ADOC regimen", | |||
"AFP-L3", | |||
"AIDS-related complex", | |||
"AIDS-related lymphoma", | |||
"AIDS Clinical Trials Group", | |||
"AIDS defining clinical condition", | |||
"AIDS dementia complex", | |||
"AMPA receptor", | |||
"ANCA associated vasculitis", | |||
"ANDEXXA", | |||
"AP (Anterior-Posterior)", | |||
"ASHICE", | |||
"ATPase", | |||
"AVNRT Slow/Fast", | |||
"AVNRT Slow/Slow", | |||
"AVPU", | |||
"AV Conduction", | |||
"AV junctional rhythms", | |||
"AV nodal ablation", | |||
"AV nodal reentrant tachycardia", | |||
"AV reentrant tachycardia", | |||
"Abacavir", | |||
"Abacavir (Patient Information)", | |||
"Abacavir adverse reactions", | |||
"Abacavir clinical pharmacology", | |||
"Abacavir clinical studies", | |||
"Abacavir contraindications", | |||
"Abacavir description", | |||
"Abacavir dosage and administration", | |||
"Abacavir how supplied", | |||
"Abacavir indications and usage", | |||
"Abacavir lamivudine", | |||
"Abacavir lamivudine adverse reactions", | |||
"Abacavir lamivudine clinical pharmacology", | |||
"Abacavir lamivudine contraindications", | |||
"Abacavir lamivudine description", | |||
"Abacavir lamivudine dosage and administration", | |||
"Abacavir lamivudine drug interactions", | |||
"Abacavir lamivudine how supplied", | |||
"Abacavir lamivudine indications and usage", | |||
"Abacavir lamivudine overdosage", | |||
"Abacavir lamivudine microbiology", | |||
"Abacavir lamivudine warnings and precautions", | |||
"Abacavir lamivudine zidovudine", | |||
"Abacavir lamivudine zidovudine adverse reactions", | |||
"Abacavir lamivudine zidovudine clinical pharmacology", | |||
"Abacavir lamivudine zidovudine contraindications", | |||
"Abacavir lamivudine zidovudine description", | |||
"Abacavir lamivudine zidovudine dosage and administration", | |||
"Abacavir lamivudine zidovudine drug interactions", | |||
"Abacavir lamivudine zidovudine how supplied", | |||
"Abacavir lamivudine zidovudine indications and usage", | |||
"Abacavir lamivudine zidovudine microbiology", | |||
"Abacavir lamivudine zidovudine overdosage", | |||
"Abacavir lamivudine zidovudine warnings and precautions", | |||
"Abacavir microbiology", | |||
"Abacavir overdosage", | |||
"Abacavir warnings and precautions", | |||
"Abagovomab", | |||
"Abatacept", | |||
"Abciximab", | |||
"Abderhalden-Kaufmann-Lignac syndrome", | |||
"Abdominal CSF pseudocyst", | |||
"Abdominal X-ray", | |||
"Abdominal angina", | |||
"Abdominal aorta", | |||
"Abdominal aortic aneurysm diagnostic study of choice", | |||
"Abdominal aortic plexus", | |||
"Abdominal cutaneous nerve entrapment syndrome", | |||
"Abdominal external oblique muscle", | |||
"Abdominal hair", | |||
"Abdominal internal oblique muscle", | |||
"Abdominal parasitic infection", | |||
"Abdominal wall defect", | |||
"Breast lumps" | |||
] | ] |
Dernière version du 25 mars 2020 à 20:17
|